Myasthenia Gravis (MG): Clinical Trials

4 trials for Myasthenia Gravis (MG), newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

2 not yet recruiting, 2 recruiting. 4 Phase 1, 1 Phase 2.

By phase and status

PhaseTrialsStatus
Phase 14Not yet recruiting 2, Recruiting 2
Phase 21Not yet recruiting 1

Follow Myasthenia Gravis (MG): new trials by email Literature Review of Myasthenia Gravis (MG) trials Research Report on Myasthenia Gravis (MG)

Trials (filtered) newest first · largest first

All 4 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
A Study of C-CAR168 in the Treatment of Autoimmune Diseases Refractory to Standard Therapy
CD20/BCMA-directed CAR-T cells Autologous 2nd generation - Multiple Sclerosis (MS), Myasthenia Gravis (MG)
Phase 1Not yet recruitingThe Affiliated Hospital of Qingdao University182026-07-012026-06-30
Safety and Pharmacodynamics of QH103 Cell Injection in the Treatment of Patients With Relapsed/Refractory Antibody-Mediated Neurological Autoimmune Diseases.
Universal CD19 CAR-γδT Cell Injection, Cyclophosphamide, Fludarabine - Multiple Sclerosis (MS), Neuromyelitis Optica Spectrum Disorder (NMOSD)
Phase 1RecruitingTongji Hospital62026-04-012026-05-12
Ripertamab for the Treatment of Myasthenia Gravis
ripertamab - Myasthenia Gravis (MG)
Phase 1 / Phase 2Not yet recruitingZhongming Qiu202026-02-012026-01-28
Phase 1 Study of HBI0101 CAR-T in Refractory B-Cell Autoimmune Diseases
HBI0101 CART - Systemic Sclerosis (SSc), Idiopathic Inflammatory Myopathy (IIM)
Phase 1RecruitingPolina Stepensky1202024-09-012026-05-06

Narrower conditions

Myasthenia Gravis (4)  ·  Multiple Sclerosis (3)  ·  Neuromyelitis Optica (3)  ·  Lupus Erythematosus, Systemic (2)  ·  Myositis (2)  ·  Scleroderma, Systemic (2)  ·  Antiphospholipid Syndrome (1)  ·  Arthritis, Rheumatoid (1)  ·  Autoimmune Diseases of the Nervous System (1)  ·  Multiple Sclerosis, Chronic Progressive (1)  ·  Polyradiculoneuropathy, Chronic Inflammatory Demyelinating (1)

Broader conditions

Autoimmune Diseases (4)  ·  Immune System Diseases (4)  ·  Neoplasms (4)  ·  Neoplasms by Site (4)  ·  Nervous System Diseases (4)  ·  Nervous System Neoplasms (4)  ·  Neurodegenerative Diseases (4)  ·  Neuromuscular Diseases (4)  ·  Neuromuscular Junction Diseases (4)  ·  Paraneoplastic Syndromes (4)  ·  Paraneoplastic Syndromes, Nervous System (4)  ·  Autoimmune Diseases of the Nervous System (3)  ·  Cranial Nerve Diseases (3)  ·  Demyelinating Autoimmune Diseases, CNS (3)  ·  Demyelinating Diseases (3)

Interventions

Cyclophosphamide (1)  ·  fludarabine (1)

Sponsors

Polina Stepensky (1)  ·  The Affiliated Hospital of Qingdao University (1)  ·  Tongji Hospital (1)  ·  Zhongming Qiu (1)

Countries

China (2)  ·  Israel (1)

Top investigators

Chuan Qin (1)  ·  Daishi Tian (1)